Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

Paller Amy S. and Seyger Marieke M. B. and Magariños Gabriel A. and Pinter Andreas and Cather Jennifer C. and Rodriguez-Capriles Claudia and Zhu Danting and Somani Najwa and Garrelts Alyssa and Papp Kim A. and Kollaborációs szervezet: IXORA-PEDS Investigators and Kemény Lajos and et al. (kollab. közrem.): Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis.
JAMA DERMATOLOGY, 158 (5). pp. 533-541. ISSN 2168-6068 (2022)

[thumbnail of jamadermatology_paller_2022_oi_220013_1659644541.564961.pdf]
Preview
Text
jamadermatology_paller_2022_oi_220013_1659644541.564961.pdf - Published Version

Download (327kB) | Preview
Item Type: Journal Article
Szerzők száma: 67
Journal or Publication Title: JAMA DERMATOLOGY
Date: 2022
Volume: 158
Number: 5
Page Range: pp. 533-541
ISSN: 2168-6068
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 33088929
DOI azonosító: https://doi.org/10.1001/jamadermatol.2022.0655
Date Deposited: 2023. Feb. 20. 10:22
Last Modified: 2023. Feb. 20. 10:22
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/26533
Web of Science® Times Cited: 16 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year